-+ 0.00%
-+ 0.00%
-+ 0.00%

EISAI PRESENTS NEW DATA ON THE CONTINUED AND EXPANDING BENEFIT OF LEQEMBI® (LECANEMAB-IRMB) MAINTENANCE TREATMENT IN EARLY ALZHEIMER'S DISEASE AT THE CLINICAL TRIALS ON ALZHEIMER'S DISEASE (CTAD) CONFERENCE 2025

Reuters·12/03/2025 23:10:02

Please log in to view news